Cargando…
Adherence to Disease-Modifying Therapies for Multiple Sclerosis
BACKGROUND: Multiple sclerosis (MS) is a neurological degenerative chronic condition without cure. However, long-term disease-modifying therapies (DMTs) help reduce the severity of MS symptoms. Adherence to DMTs is key to their success. Several studies have analyzed what makes patients adherent to t...
Autores principales: | Higuera, Lucas, Carlin, Caroline S., Anderson, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397889/ https://www.ncbi.nlm.nih.gov/pubmed/27882830 http://dx.doi.org/10.18553/jmcp.2016.22.12.1394 |
Ejemplares similares
-
Adherence to disease-modifying therapies in patients with multiple sclerosis
por: Kołtuniuk, Aleksandra, et al.
Publicado: (2018) -
Predictors of adherence and persistence to disease-modifying therapies in Multiple Sclerosis
por: Zanga, Gisela, et al.
Publicado: (2021) -
Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis
por: Alosaimi, Fahad D, et al.
Publicado: (2017) -
Association between multiple sclerosis disease severity and adherence to disease-modifying therapies
por: Burkhard, Adam, et al.
Publicado: (2021) -
The Impact of Adherence to Disease-Modifying Therapies on Functional Outcomes in Veterans with Multiple Sclerosis
por: Rabadi, Meheroz H, et al.
Publicado: (2021)